We have seen in the last few days a dynamic resistance that characterized the pull back of the price from a threshold range between 16.95-16.75. Today the lowest minimum price touched 16.00 dollars (around -2% compare to opening). Violent and prompt reaction with high volatility intraday had set the price at 16.45 +0.3%. 16$ was the point where the ascendant trend...
This is my first wave chart, so be gentle. :)
i have 2 scenario. One is that wave 5 have ended and we are ready to a correctional wave of A,B,C.
The other is that they will present bad revenue. And the price will continue the down trend, and stop at the support line at 6,49
where the 5th wave could end and start a correction of A,B,C.
Fundamental:
Teva have a...
Gilead's core product pipeline, including recent FDA approval is set to soar as key drugs and generics are continuing to outperform.
The company's recent acquisition of KITE Pharma came at the perfect moment with KITE being granted a key drug approval by the FDA.
Gilead's recent cost cutting efforts and R&D focus are to further push growth prospect and boost...
Johnson & Johnson has been on an impressive intra-quarterly run with solid performance across major segments.
Strengths in the company's performance are to be driven by:
-Imbruvica and Darzalex should continue to perform well. Meaningful improvement from Stelara and Xarelto.
-New product launches like Tremfy (approved in the US late 2017 for plaque...
Although the ideas I share with you all revolve around currency pairs, I thought I'd share another specialty of mine: Biotech and pharma stock. If you're in the field, you may have already heard about Gilead having one of the best price to earning ratio of the major biotech companies. You may have also noticed the sharp decline that they experienced in the summer...
Very pleased to see new life being breathed into this stock based on the news today
Article - finance.yahoo.com
Fingers crossed for another big move upward next week.
Gonna be a long weekend, have fun and stay safe
Buying dips on BMS Stock. Watch for the 55.20-54.70$ area.
I am targeting for now 60$ and stop should not be placed too far away. 53/52$ seems reasonable to have a nice R:R.
Hourly Chart:
Watch the corrective channel, this might setup a nice long opportunity.
Blessings to you all.
To continue higher PRGO will have to break above the top of the channel and the 200 MA line.
Bears can look for bearish reversal signs inside this resistance zone.
Huge breakout for ABBV closing the day above the double top formed from 2014/2015 highs between 70.70 and 71.60, both offering little resistance. RSI pushing into the high 80s shows good strong move up in my opinion, I won't be using RSI for short/sell/TP signal, rather buy more when it dips to over-sold territory on consolidation in the next few weeks... if that...
Aurobindo Pharma is another great company one should have in their investment portfolio and this is a very good time to buy/add this stock around 580-600 levels.
Expecting it to give 20% + returns annually from here and wouldn't be surprised if it is much more than that..
Nothing entirely new to report. Closed above last major resistance and still continues to stair step in the right direction. I think it should be noted and I didn't mention it before but the corporations who took a stake in the company in the last two months:
Maxim Group set a $4.00 price target on shares of ContraVir Pharmaceuticals and gave the stock a “buy”...
$CBIO Recent Highlights and Upcoming Milestones
Recent Highlights:
Catalyst Biosciences’ Factor IX Recommended for Orphan Drug Designation in Europe
Contract revenue for the three months ended March 31, 2017 was $0.3 million, compared with $0.1 million for the prior year period. The increase in contract revenue was due to the milestone revenue from ISU Abxis...
